Sensorion

About:

Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.

Website: https://www.sensorion.com/

Top Investors: Invus, Sofinnova Partners, Redmile Group, Crede CapitalGroup, Aquilo Capital Management

Description:

Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.

Total Funding Amount:

98.3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Clapiers, Languedoc-Roussillon, France

Founded Date:

2009-01-01

Contact Email:

contact(AT)sensorion-pharma.com

Founders:

Christian Chabbert

Number of Employees:

51-100

Last Funding Date:

2024-02-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai